The effect of dual PPAR α/γ stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients S Seber, S Ucak, O Basat, Y Altuntas Diabetes research and clinical practice 71 (1), 52-58, 2006 | 69 | 2006 |
Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials T Korkmaz, S Seber, G Basaran Critical reviews in oncology/hematology 98, 180-188, 2016 | 68 | 2016 |
Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients Ö Harmankaya, S Seber, M Yılmaz Renal failure 25 (3), 465-470, 2003 | 67 | 2003 |
Primary renal carcinoid: treatment and prognosis T Korkmaz, S Seber, D Yavuzer, M Gumus, NS Turhal Critical Reviews in Oncology/Hematology 87 (3), 256-264, 2013 | 60 | 2013 |
Outcomes of platinum-sensitive small-cell lung cancer patients treated with platinum/etoposide rechallenge: a multi-institutional retrospective analysis G Genestreti, M Tiseo, H Kenmotsu, W Kazushige, M Di Battista, ... Clinical lung cancer 16 (6), e223-e228, 2015 | 53 | 2015 |
Protective effects of onion (Allium cepa) extract against doxorubicin-induced hepatotoxicity in rats R Mete, M Oran, B Topcu, M Oznur, ES Seber, A Gedikbasi, T Yetisyigit Toxicology and industrial health 32 (3), 551-557, 2016 | 52 | 2016 |
Recurrent pericarditis as the initial manifestation of familial Mediterranean fever K Okutur, S Seber, E Oztekin, C Bes, F Borlu Medical Science Monitor 14 (12), CS139-CS141, 2008 | 46 | 2008 |
Visceral adipose tissue as an indicator of insulin resistance in nonobese patients with new onset type 2 diabetes mellitus O Basat, S Ucak, H Ozkurt, M Basak, S Seber, Y Altuntas Experimental and clinical endocrinology & diabetes 114 (02), 58-62, 2006 | 41 | 2006 |
After myocardial infarction carvedilol improves insulin resistance compared to metoprolol O Basat, S Ucak, S Seber, E Oztekin, Y Altuntas Clinical research in cardiology 95, 99-104, 2006 | 39 | 2006 |
Retrospective evaluation of totally implantable venous access port devices: early and late complications S Gurkan, S Seber, O Gur, T Yetisyigit, M Okan Donbaloglu, ... J buon 20 (1), 338-345, 2015 | 30 | 2015 |
Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer T Korkmaz, S Seber, K Okutur, G Basaran, F Yumuk, F Dane, T Ones, ... Biomarkers 18 (1), 88-94, 2013 | 30 | 2013 |
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis T Korkmaz, S Seber, U Kefeli, E Sari, M Canhoroz, B Oven, E Yildirim, ... Clinical and Translational Oncology 15, 535-540, 2013 | 24 | 2013 |
Clinical outcome of breast cancer patients with N3a (≥ 10 positive lymph nodes) disease: has it changed over years? G Basaran, C Devrim, HB Caglar, B Gulluoglu, H Kaya, S Seber, ... Medical Oncology 28, 726-732, 2011 | 23 | 2011 |
Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes H Sargin, M Sargin, Y Altuntaş, AM Şengül, E Orbay, S Seber, S Uçak, ... Diabetes research and clinical practice 62 (2), 79-86, 2003 | 22 | 2003 |
Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line S Seber, DY Sirin, T Yetisyigit, T Bilgen Nigerian journal of clinical practice 23 (3), 386-391, 2020 | 17 | 2020 |
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer E Cavdar, Y Iriagac, K Karaboyun, O Avci, ES Seber Journal of Geriatric Oncology 13 (6), 821-827, 2022 | 16 | 2022 |
Breast cancer in young and very young women; Is age related to outcome? O Avci, SY Tacar, ES Seber, T Yetisyigit Journal of cancer research and therapeutics 17 (6), 1322-1327, 2021 | 16 | 2021 |
Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities-single center experience D Cabuk, G Basaran, M Teomete, F Dane, T Korkmaz, S Seber, F Telli, ... Asian Pacific Journal of Cancer Prevention 15 (1), 117-122, 2014 | 16 | 2014 |
Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer K Okutur, S Seber, T Korkmaz Journal of BUON 17, 669-676, 2012 | 13 | 2012 |
Rhabdomyolysis and severe haemolytic anaemia, hepatic dysfunction and intestinal osteopathy due to hypophosphataemia in a patient after Billroth II gastrectomy Y Altuntas, M Innice, T Basturk, S Seber, G Serin, B Ozturk European journal of gastroenterology & hepatology 14 (5), 555-557, 2002 | 12 | 2002 |